To request review copies [email protected] Back to contents 4 Medicine Biomarkers in Cancer Screening and Early Detection Sudhir Srivastava Division of Cancer Prevention, National Cancer Institute, Bethesda, MD, USA Series: Translational Oncology ISBN: 978-1-118-46880-7 | Apr 2017 | 304PP Prepared by world leaders on this topic, Biomarkers in Cancer Screening and Early Detection offers a comprehensive, state-of-the-art perspective on the various research and clinical aspects of cancer biomarkers, from their discovery and development to their validation, clinical utility, and use in developing personalized cancer treatment. •• Offers a comprehensive, state-of-the-art perspective on the various research and clinical aspects of cancer biomarkers •• Provides immediately actionable information—and hopefully also inspiration— to move discovery and clinical application forward •• Offers vital knowledge to help develop personalized cancer treatment for individual patients with specific cancers About the Editor Sudhir Srivastava is Chief of the Cancer Biomarkers Research Group at the National Cancer Institute in Bethesda, Maryland, USA. Dr Srivastava has received many honors and awards and is a member of several scientific committees. He has published more than 200 research papers, review articles and commentaries in peer reviewed journals, and has edited two books: Informatics in Proteomics and Nanotechnology for Cancer Detection and Diagnosis (forthcoming). He is also the Editor-in Chief of the journals Disease Markers and Cancer Biomarkers.
STM_Jan2017
To see the actual publication please follow the link above